Vikas Lifecare Limited (VIKASLIFE)

Loading page…

Vikas Lifecare Limited (VIKASLIFE) · mywealthgrid

About

Vikas Lifecare Limited operates as a trading and distribution business in Commercial Services & Supplies within the Industrials sector. With a market capitalization of ₹228.5 Crores and quarterly revenue ranging from ₹96–169 Crore, it is a small-cap distributor. However, the company has faced persistent profitability challenges with consistently negative operating margins.

Face value: ₹1

Market cap

₹223 Cr

P/E

—

P/B

0.4×

Dividend yield

ROE

3.4%

ROCE

13.8%

Debt / equity

0.19

OPM

-9.7%

EPS (TTM)

₹-0.6

Book value

₹3.0

52-week high

—

52-week low

—

Key insights

Company research notes and source-linked reviews

Key risks

Operating margins remain deeply negative at -9.68% overall and worsen to -16.14% in recent quarters, suggesting fundamental issues in the distribution or trading model
Quarterly net profit is highly volatile, ranging from -₹118.96 Cr in Sep 2025 to +₹41.6 Cr in Mar 2026 despite modest revenue changes, indicating operational instability or significant one-time items
Very low promoter ownership (14.2%) combined with zero domestic institutional investor participation (DII 0%, FII 0.26%) reflects weak conviction in management
Stock has declined 44.59% over one year and ROE stands at just 3.4%, signaling sustained investor skepticism about capital efficiency

Generated analysis · source review pending

Growth drivers

Revenue recovered to ₹165–169 Cr in Mar 2026 from a ₹96–97 Cr low in Dec 2025, indicating the business can return to higher-revenue quarters if demand stabilizes
Operating losses of -9.68% mean even modest margin recovery toward breakeven would materially amplify earnings from the ₹129–169 Cr revenue base
Debt-to-equity ratio of 0.19 is low, providing financial flexibility to invest in cost reduction or working-capital optimization
Trading and distribution businesses typically stabilize when supply-chain disruptions ease; verify whether your sector indicators confirm a normalization cycle

Generated analysis · source review pending

1,826 historical price candles were omitted because the exchange source has not been verified.

₹1.2-0.8%1Y

Quick read

rule-based

Pros

+Revenue CAGR of 46.1% over the last 5 years
+Comfortable interest coverage of 12.5×

Cons

−Low return on equity of 1.6% (3-yr avg)
−Low promoter holding of 14.2%

Research score

Structured signal from quality, growth, valuation and momentum.

65/100

Business quality: 40
Growth: 53
Valuation: 100

Revenue & net profit

₹ crore, by fiscal year

RevenuePAT

Margins

% of revenue, by fiscal year

OPMPAT margin

Peers

Comparable companies from the narrowest available industry classification.

Screen this industry Compare top 5 side-by-side

Loading peers…

Financials

Reported profit and loss, balance sheet, cash flow and growth history.

Annual Quarterly

Consolidated Standalone

Consolidated figures · ₹ crore

₹ Cr	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	75	301	476	446	480	499
COGS	64	291	452	419	465	484
Gross profit	11	10	24	26	15	16
	3	11	13	22	37	132
	8	-1	12	4	-22	-116
OPM %	10.4%	-0.3%	2.5%	1%	-4.5%	-23.3%
Depreciation	1	2	3	4	7	6
Interest	5	2	2	3	5	7
	-3	44	-28	19	20	136
Profit before tax	-2	39	-21	17	-13	7
Tax	2	10	-6	4	-2	-11
Tax %	133.3%	25.9%	-27.4%	21.3%	-15.2%	-157.3%
	-4	29	-16	13	-11	18
PAT margin %	-4.7%	9.6%	-3.3%	3%	-2.3%	3.7%
EPS (₹)	-0.1	0.3	-0.1	0.1	-0	0.1
EPS adjusted (₹)	-0.1	0.3	-0.1	0.1	-0.1	0.1
Annual report	Annual report for Mar 2021	Annual report for Mar 2022	Annual report for Mar 2023	Annual report for Mar 2024	Annual report for Mar 2025	—

₹ Cr	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity capital	66	66	110	144	165	186	186
Reserves	—	0	90	187	311	346	366
Minority interest	—	—	0	2	2	1	0
	—	42	23	30	34	76	105
	—	41	98	91	42	120	103
Total equity & liabilities	—	149	321	455	555	729	760
	4	4	22	41	38	53	35
CWIP	—	—	—	0	0	1	0
Investments	—	11	91	83	190	61	395
	0	133	208	330	327	614	330
Total assets	5	149	321	455	555	729	760

Segment results

As reported in NSE results XBRL. Segment result is before tax and finance costs.

Source XBRL ↗

Latest reported period · 31 Mar 2026 · ₹ crore

Segment	Revenue	Result	Assets	Liabilities
Trading & Manufacturing Division -Agro	406.84	12.06	0	0
Trading & Maniufacturing Division -Infrastructure	61.27	-0.63	0	0
Trading & Manufacturing Division -Polymers	27.26

Loading financials…

Ratios

Annual operating, return, leverage and working-capital ratios.

Consolidated Standalone

Consolidated figures

Ratio	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Margins
Gross margin %	15%	3.4%	5.1%	5.9%	3.1%	3.1%
EBITDA margin %	10.4%	-0.3%	2.5%	1%	-4.5%	-9.7%
EBIT margin %	9.4%	-0.8%	1.8%	0.2%	-5.9%	-10.9%
PAT margin %	-4.7%	9.6%	-3.3%	3%	-2.3%	3.7%
Working capital
Receivable days	347	62	130	120	97	103
Inventory days	156	36	10	8	4	4
Payable days	216	84	48	13	47	44
NWC days	287	14	93	115	54	62
Leverage
Current ratio	1.84	1.22	2.14	4.47	1.75	1.65
Debt to EBITDA	5.38	—	2.59	7.95	—	—
Debt to equity	0.63	0.12	0.09	0.07	0.14	0.19
Interest coverage	1.5	19.1	-8.3	9.4	-0.5	12.5
Asset turnover	0.5	0.94	1.05	0.8	0.66	0.66
Return ratios
Return on assets %	-2.3%	9%	-3.4%	2.4%	-1.5%	2.4%
Return on capital employed %	9.8%	27.6%	-6.8%	6.3%	-0.4%	13.8%
Return on equity %	-5.2%	14.5%	-4.7%	2.8%	-2.1%	3.3%

Derived from reported annual statements. ROCE uses EBIT over capital employed (total assets less current liabilities). Day counts average the opening and closing balance; receivables turn on revenue, inventory and payables on cost of goods sold.

Loading ratios…

Shareholding

Quarterly ownership, named holders, insider transactions and disclosed deals.

Quarterly Annual

Every quarter filed · % of equity

Holder (%)	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
	11.4%	11.4%	11.4%	11.39%	14.21%	11.39%	14.2%	14.2%	14.2%	14.2%	14.2%	14.2%
	0.02%	0.02%	0.02%	10.49%	0.28%	0.55%	0.49%	0.46%	0.38%	0.3%	0.28%	0.26%
DII	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%
Government	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%
	88.58%	88.58%	88.58%	78.12%	85.51%	88.06%	85.31%	85.34%	85.42%	85.5%	85.52%	85.54%
No. of shareholders	—	—	—	—	—	—	—	—	—	8,10,062	7,95,499	7,81,107

Promoter holding up 2.8 percentage points since Jun 2023.

247 deals · 20 Oct 2021 – 17 Apr 2025

Date	Client	Type	Venue	Side	Quantity	Price	Value
17 Apr 2025	SYLPH TECHNOLOGIES LIMITED	Bulk	NSE	Sell	2,12,61,803	₹2.52	₹5.36 Cr
15 May 2024	ANKITA VISHAL SHAH	Bulk	NSE	Buy	89,18,889	₹5.09	₹4.54 Cr
15 May 2024	ANKITA VISHAL SHAH	Bulk	NSE	Sell	39,26,174	₹5.14	₹2.02 Cr
29 Jan 2024	HI GROWTH CORPORATE SERVICES PVT LTD	Bulk	NSE	Sell	1,13,45,629	₹7.54	₹8.55 Cr
29 Jan 2024	HI GROWTH CORPORATE SERVICES PVT LTD	Bulk	NSE	Buy	1,11,96,551	₹7.53	₹8.43 Cr
25 Jan 2024	CITADEL SECURITIES INDIA MARKETS PRIVATE LIMITED	Bulk	NSE	Sell	1,00,82,425	₹7.53	₹7.59 Cr
24 Jan 2024	HRTI PRIVATE LIMITED	Bulk	NSE	Buy	1,37,38,157	₹7.57	₹10.40 Cr
24 Jan 2024	HRTI PRIVATE LIMITED	Bulk	NSE	Sell	1,19,73,729	₹7.56	₹9.05 Cr
24 Jan 2024	GRAVITON RESEARCH CAPITAL LLP	Bulk	NSE	Sell	85,12,005	₹7.58	₹6.45 Cr
24 Jan 2024	GRAVITON RESEARCH CAPITAL LLP	Bulk	NSE	Buy	85,12,005	₹7.57	₹6.44 Cr

1–10 of 247

1 / 25

Mr. SUNDEEP KUMAR DHAWANExecutive Director-Chairperson-MD
Mr. ANIL KUMARNon-Executive - Independent Director
Mrs. RICHA SHARMANon-Executive - Independent Director
Mr. CHANDAN KUMARExecutive Director
Mr. VIJAY KUMAR GOELNon-Executive - Independent Director
Mr. ANIL KUMAR RAWALExecutive Director
Mr. Shri Pal GoelNon-Executive - Independent Director
Mr. Amit JindalChief Executive Officer
Mr. KAMAL GHIDIYALExecutive Director
Mr. Kamal GhildiyalChief Operating Officer
Mr. Sanjay Kumar JaiswalCompany Secretary & Compliance Officer

Current officeholders as filed with BSE. A person holding two offices is listed once per office.

Loading shareholding…

F&O

Current futures and options contracts with compact option-chain pages.

Not in the F&O segment

Only about 210 stocks have listed futures and options. Contracts appear here for those, refreshed after each close.

Loading f&o…

Fund holders

Mutual-fund schemes that disclosed a holding in the company.

No fund holdings on record

No scheme among the 32 fund houses on record reported a position in Vikas Lifecare Limited. Portfolios are published monthly by each AMC; coverage is still partial.

Loading fund holders…

Documents

Annual reports, exchange filings, offer documents, ratings and earnings-call material.

Announcements

Loading documents…

Events

Upcoming dates and the company’s corporate-action history.

No events on record

Corporate actions, results dates and filings will appear here once ingested.

Loading events…

Announcements

Latest exchange announcements, filings and downloadable documents.

1 month 3 months 6 months 1 year All

5 announcementsExport CSV

17 Sept 2026, 3:18 pmOthers

Intimation Of Approval For Extension Of Time For Holding Annual General Meeting (AGM) For The Financial Year Ended March 31, 2026

Exchange filing PDF

8 Sept 2026, 7:21 pmCompany Update

Vikas Lifecare Ltd - 542655 - Disclosure Under Regulation 30 Of The SEBI (LODR) Regulations, 2015 Intimation Regarding Application For Extension Of AGM

General PDF

15 Jul 2026, 9:27 pmCompany Update

Disclosure Under Regulation 30 Of The SEBI (LODR) Regulations, 2015

General PDF

11 Jul 2026, 4:57 pmCompany Update

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 PDF

9 Jul 2026, 4:54 pmCompany Update

Outcome Of Board Meeting Held On 24Th June, 2026

General PDF

Date	Category	Subject	Filing
17 Sept 2026, 3:18 pm	Others	Intimation Of Approval For Extension Of Time For Holding Annual General Meeting (AGM) For The Financial Year Ended March 31, 2026	PDF
8 Sept 2026, 7:21 pm	Company Update General	Vikas Lifecare Ltd - 542655 - Disclosure Under Regulation 30 Of The SEBI (LODR) Regulations, 2015 Intimation Regarding Application For Extension Of AGM

Loading announcements…

Ratio	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Margins
Gross margin %	15%	3.4%	5.1%	5.9%	3.1%	3.1%
EBITDA margin %	10.4%	-0.3%	2.5%	1%	-4.5%	-9.7%
EBIT margin %	9.4%	-0.8%	1.8%	0.2%	-5.9%	-10.9%
PAT margin %	-4.7%	9.6%	-3.3%	3%	-2.3%	3.7%
Working capital
Receivable days	347	62	130	120	97	103
Inventory days	156	36	10	8	4	4
Payable days	216	84	48	13	47	44
NWC days	287	14	93	115	54	62
Leverage
Current ratio	1.84	1.22	2.14	4.47	1.75	1.65
Debt to EBITDA	5.38	—	2.59	7.95	—	—
Debt to equity	0.63	0.12	0.09	0.07	0.14	0.19
Interest coverage	1.5	19.1	-8.3	9.4	-0.5	12.5
Asset turnover	0.5	0.94	1.05	0.8	0.66	0.66
Return ratios
Return on assets %	-2.3%	9%	-3.4%	2.4%	-1.5%	2.4%
Return on capital employed %	9.8%	27.6%	-6.8%	6.3%	-0.4%	13.8%
Return on equity %	-5.2%	14.5%	-4.7%	2.8%	-2.1%	3.3%

Company	Mkt Cap	EV	Revenue	EBITDA	OPM	PAT	NPM	ROCE	ROE	WC Days
Redington LimitedREDINGTONREDINGTON	₹31,112 Cr	₹33,749 Cr	₹1,28,133 Cr	₹2,537 Cr	1.9%	₹1,701 Cr	1.1%	21.7%	15.8%	34
Mmtc LimitedMMTCMMTC	₹8,444 Cr	₹8,444 Cr	₹3 Cr	₹-179 Cr	—	₹447 Cr	—	-0.5%	20.3%	-2,38,864
Mstc LimitedMSTCLTDMSTCLTD	₹4,969 Cr	₹5,114 Cr	₹386 Cr	₹236 Cr	60.6%	₹234 Cr	59.1%	34.9%	26.6%	-92
Bn Agrochem LimitedBNAGROCHEMBNAGROCHEM	₹2,228 Cr	₹2,310 Cr	₹299 Cr	₹-37 Cr	-12.5%	₹20 Cr	6.6%	12%	8.5%	130
Creative Newtech LimitedCNLCNL	₹1,619 Cr	₹1,943 Cr	₹2,783 Cr	₹99 Cr	3.2%	₹74 Cr	2.6%	29.2%	21.4%	75
Pervasive Commodities LtdPERVASIVEPERVASIVE	₹1,090 Cr	₹1,090 Cr	₹43 Cr	₹-0 Cr	-1.1%	₹-0 Cr	-0.1%	0%	-0.1%	548
RRP Defense LtdRRPDEFENSERRPDEFENSE	₹842 Cr	₹844 Cr	₹12 Cr	₹-1 Cr	-8.4%	₹-1 Cr	-8.2%	-13.7%	-13.7%	-15
The Yamuna Syndicate LtdYSLYSL	₹779 Cr	₹779 Cr	₹69 Cr	₹2 Cr	2.2%	₹52 Cr	75.3%	0.3%	4%	60
The State Trading Corporation Of India LimitedSTCINDIASTCINDIA	₹636 Cr	₹1,811 Cr	₹0 Cr	₹-46 Cr	—	₹21 Cr	—	—	—	—
SMT Engineering LtdSMTELSMTEL	₹598 Cr	₹679 Cr	₹162 Cr	₹41 Cr	25%	₹23 Cr	14.2%	33.2%	25.2%	395
Bijoy Hans LtdARVAYAARVAYA	₹576 Cr	₹579 Cr	₹0 Cr	₹-1 Cr	—	₹0 Cr	—	-3.9%	-3.9%	—
Riddhi Siddhi Gluco Biols LtdRIDDHIRIDDHI	₹505 Cr	₹787 Cr	₹236 Cr	₹-12 Cr	-5.2%	₹61 Cr	-5.2%	2.8%	-0.8%	65

₹ Cr	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	-8	-15	-110	-42	-222	310
	12	-39	-37	-91	106	-334
	-4	59	151	137	108	20
Net cash flow	-0	6	4	4	-8	-5
Free cash flow	-9	-17	-128	-58	-222	308
CFO / Operating profit %	-99.1%	—	-937.1%	-962%	—	—

Vikas Lifecare Limited

About

Key insights

Key risks

Growth drivers

Quick read

Pros

Cons

Research score

Revenue & net profit

Margins

Peers

Financials

Segment results

Ratios

Shareholding

F&O

Not in the F&O segment

Fund holders

No fund holdings on record

Documents

Announcements

Events

No events on record

Announcements

Not in the F&O segment

No events on record

No fund holdings on record

Announcements

Annual reports

Segment results

Compounded sales growth

Return on equity

Income From Advertisement and Sponsorship Services · revenue

Vikas Lifecare Limited

About

Key insights

Key risks

Growth drivers

Quick read

Pros

Cons

Research score

Revenue & net profit

Margins

Peers

Financials

Profit & loss

Balance sheet

Segment results

Ratios

Ratio timeline

Shareholding

Quarterly record

Bulk & block deals

Board and management

F&O

Not in the F&O segment

Fund holders

No fund holdings on record

Documents

Announcements

Events

No events on record

Announcements

Not in the F&O segment

Ratio timeline

No events on record

No fund holdings on record

Quarterly record

Bulk & block deals

Board and management

Announcements

Annual reports

Profit & loss

Balance sheet

Segment results

Cash flow

Compounded returns

Compounded sales growth

Return on equity

Income From Advertisement and Sponsorship Services · revenue